Frontlight ResearchEarly access
Mesothelioma trials in Netherlands
3 of 5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopledENdritic Cell Therapy Combined With SURgEry in Mesothelioma
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 16
- Run by
- Erasmus Medical Center
See details and how to joinNCT05304208 - Phase 2Not yet taking people in NetherlandsGiving Upfront Anti-p40 to Reduce toxicity from Dual Immune Checkpoint Inhibition in Mesothelioma
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 42
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2026-526036-38-00 - Phase 2Taking peopleIMMUNOPEC: Combination of neo-adjuvant Checkpoint Inhibition and Dendritic Cell Therapy (MesoPher) with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in patients with Peritoneal Mesothelioma
- Where
- Rotterdam
- Age
- 18 years and over
- People
- 18
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2024-519626-21-00